Skip to main content

Table 4 Multivariate analysis of variables associated with overall survival in patients undergoing repeat TACE

From: Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation

Overall cohort n = 292    
VariableHazard RatioLower 95% CIHigher 95% CIP value
Baseline tumour number, 1, 2,3, > 31.181.031.360.020
Bilirubin post TACE 11.021.001.030.007
AFP ≥ 200 ng/ml post TACE 12.131.343.400.001
Decompensation post TACE 24.501.8610.890.001